Subscribe to Updates in Healthcare

RSS By Email

RSS By RSS

Add to Google Reader or Homepage

Subscribe in Bloglines


The Expertise Imperative and Compliance Technology
Access to a diverse array of specialized expert inputs drives superior decisions in every organizational context: within corporations, by investors and consultancies, and within nonprofits. When decision makers are confident of their decision inputs, they can respond more quickly and creatively to challenges and opportunities.Learn more about GLG's Compliance Framework


This page may include content provided by Council Members, your access to which is subject to the Terms of Use.
Find Out More

July 3, 2008

An illegal use of Lumigan, now legal?

Analysis of: Longer Lashes in a Tube? Maybe Not | www.nytimes.com
This analysis is solely the work of the author. It has not been edited or endorsed by GLG.
Analysis By:
Steve Rubinstein, OD, OptometristSteve Rubinstein, OD
Optometrist, Sound Shore Vision Care
Implications: A few months ago, a small company tried to import Lumigan (bimatoprost), licensed by Allergan, in an eyelash applicator. It was held by the FDA as an unapproved use of a prescription medication. Now the owner of the patent is trying to import the same drug legally.

Analysis: I just find it interesting that an unintended use of a drug can be so contentious. I also wonder if the packaging will also tell the public that in addition to promoting eyelash growth, it can change the color of your eyes.

Another unintended effect of Lumigan is to make blue eyes brown. I wonder if application to the eyelash will do the same as a drop and increase iris pigmentation?

I guess we will see what the marketing geniuses will do when the complaints start coming in.


Report a Concern

GLG News: What Experts Think Is Important





Analytics


Generated at 2008-09-05T05:45:18.073